Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does AVELUMAB Cause Hepatic function abnormal? 40 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 40 reports of Hepatic function abnormal have been filed in association with AVELUMAB (BAVENCIO). This represents 1.1% of all adverse event reports for AVELUMAB.

40
Reports of Hepatic function abnormal with AVELUMAB
1.1%
of all AVELUMAB reports
5
Deaths
22
Hospitalizations

How Dangerous Is Hepatic function abnormal From AVELUMAB?

Of the 40 reports, 5 (12.5%) resulted in death, 22 (55.0%) required hospitalization, and 1 (2.5%) were considered life-threatening.

Is Hepatic function abnormal Listed in the Official Label?

Yes, Hepatic function abnormal is listed as a known adverse reaction in the official FDA drug label for AVELUMAB.

What Other Side Effects Does AVELUMAB Cause?

Death (361) Disease progression (355) Off label use (200) Diarrhoea (153) Infusion related reaction (142) Pyrexia (129) Fatigue (124) Neoplasm progression (119) Dyspnoea (100) Nausea (99)

What Other Drugs Cause Hepatic function abnormal?

NIVOLUMAB (1,131) PEMBROLIZUMAB (1,079) METHOTREXATE (1,054) CABOZANTINIB S-MALATE (912) CYCLOPHOSPHAMIDE (824) BEVACIZUMAB (769) PACLITAXEL (603) LENVATINIB (528) ATORVASTATIN (520) CYCLOSPORINE (508)

Which AVELUMAB Alternatives Have Lower Hepatic function abnormal Risk?

AVELUMAB vs AVIBACTAM AVELUMAB vs AVIBACTAM\CEFTAZIDIME AVELUMAB vs AVOBENZONE\HOMOSALATE\OCTINOXATE\OCTISALATE\OCTOCRYLENE\OXYBENZONE\TITANIUM DIOXIDE\ZINC AVELUMAB vs AVOBENZONE\HOMOSALATE\OCTINOXATE\OCTISALATE\OXYBENZONE AVELUMAB vs AVOBENZONE\HOMOSALATE\OCTISALATE\OCTOCRYLENE

Related Pages

AVELUMAB Full Profile All Hepatic function abnormal Reports All Drugs Causing Hepatic function abnormal AVELUMAB Demographics